| Current dividend yield | 4.69 % |
| Dividendenrendite 5 Jahre | 2.27 % |
| Dividend Yield 10Y | 8.95 % |
| Payout 3Y | 6.05 % |
| Year | Dividend | Ex-day & Payday |
Frequency | |
|---|---|---|---|---|
| Fiscal Year | Dividend per Share | Ex-Day | Payday | Payment frequency |
| 2026 |
£0.795
£0.8
|
Aug 06 2026
Aug 06 2026
Sep 08 2026
Aug 06 26
Sep 08 26 |
Sep 08 2026 |
-
-
|
| 2025 |
£1.595
£1.6
|
Feb 19 2026
Feb 19 2026
Mar 23 2026
Feb 19 26
Mar 23 26 |
Mar 23 2026 |
-
-
|
| 2025 |
£0.767
£0.77
|
Aug 07 2025
Aug 07 2025
Sep 08 2025
Aug 07 25
Sep 08 25 |
Sep 08 2025 |
-
-
|
| 2024 |
£1.68
£1.68
|
Feb 20 2025
Feb 20 2025
Mar 24 2025
Feb 20 25
Mar 24 25 |
Mar 24 2025 |
-
-
|
| 2024 |
£0.776
£0.78
|
Aug 08 2024
Aug 08 2024
Sep 09 2024
Aug 08 24
Sep 09 24 |
Sep 09 2024 |
-
-
|
| 2023 |
£1.56
£1.56
|
Feb 22 2024
Feb 22 2024
Mar 25 2024
Feb 22 24
Mar 25 24 |
Mar 25 2024 |
-
-
|
| 2023 |
£0.718
£0.72
|
Aug 10 2023
Aug 10 2023
Sep 11 2023
Aug 10 23
Sep 11 23 |
Sep 11 2023 |
-
-
|
| 2022 |
£1.628
£1.63
|
Feb 23 2023
Feb 23 2023
Mar 27 2023
Feb 23 23
Mar 27 23 |
Mar 27 2023 |
-
-
|
| 2022 |
£0.764
£0.76
|
Aug 11 2022
Aug 11 2022
Sep 12 2022
Aug 11 22
Sep 12 22 |
Sep 12 2022 |
-
-
|
| 2021 |
£1.453
£1.45
|
Feb 24 2022
Feb 24 2022
Mar 28 2022
Feb 24 22
Mar 28 22 |
Mar 28 2022 |
-
-
|
AstraZeneca most recently paid a dividend of £0.80. AstraZeneca paid a Dividend of £2.36 Per Share in the financial year 2025. With a stock price of £124.28 at Sep 29 2026, the current dividend yield is 1.90% (calculation: £2.36 / £124.28 = 1.90%). No special dividend was paid.
The average AstraZeneca dividend yield over the last 5 years is 2.36% and the average over the last 10 years is 3.03%.
The payout ratio of AstraZeneca in relation to the last financial year is 47.72%. The payout ratio smoothed over 3 years is 63.19%. The calculation is based on the sum of all dividend payments divided by the cumulative earnings per share(EPS).
| Metric | AstraZeneca |
|---|---|
| Current dividend yield | 1.90% |
| Dividend Yield 5Y | 2.36% |
| Dividend Yield 10Y | 3.03% |
| Payout 1Y | 47.72% |
| Payout 3Y | 63.19% |
AstraZeneca has been paying a dividend for 25 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
The Dividend Growth in relation to the previous financial year amounts to -3.83%. The average AstraZeneca Dividend Growth over the last 5 years is 2.67%. The average for the last 10 years is 2.28%.
| Metric | AstraZeneca |
|---|---|
| Increased | 0 Years |
| Continuity | 0 Years |
| Paid | 25 Years |
| Growth 1Y | -3.83% |
| Growth 5Y | 2.67% |
| Growth 10Y | 2.28% |
AstraZeneca has been paying a dividend for 25 years and has not lowered the dividend for 0 years (dividend continuity). As a result, the dividend was not increased recently.
The Dividend Growth in relation to the previous financial year amounts to -3.83%. The average AstraZeneca Dividend Growth over the last 5 years is 2.67%. The average for the last 10 years is 2.28%.
On the stock exchange, the AstraZeneca stock (ISIN: GB0009895292) is not traded as a top scorer in September 2026 according to the dividend strategy.
The stock price of AstraZeneca -8.34% has fallen since the beginning of the year 2026. However, the return generated in the past says nothing about the future return. You can find the AstraZeneca stock price in real time at the top of the page.
AstraZeneca (symbol: AZN) is valued at a Price / Earnings Ratio (P/E ratio) of 24.56 and a price/sales ratio (P/S ratio) of 4.18 valued. Based on analyst estimates, the AstraZeneca stock forecast 2026 of the current financial year corresponds to a valuation of 15.78 according to P/E ratio and 3.94 according to P/S.
| Metric | AstraZeneca |
|---|---|
| Dividend Score | ??/15 |
| Performance 2026 |
8.34%
|
| P/E TTM | 24.56 |
| P/S TTM | 4.18 |
| P/E forward | 15.78 |
| P/S forward | 3.94 |
AstraZeneca (symbol: AZN) is valued at a Price / Earnings Ratio (P/E ratio) of 24.56 and a price/sales ratio (P/S ratio) of 4.18 valued. Based on analyst estimates, the AstraZeneca stock forecast 2026 of the current financial year corresponds to a valuation of 15.78 according to P/E ratio and 3.94 according to P/S.
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


